

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 7.54365852 |
| 2 | epoxygenase P450 pathway (GO:0019373) | 7.31787607 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.11817451 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 7.11817451 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.94847321 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 6.94847321 |
| 7 | omega-hydroxylase P450 pathway (GO:0097267) | 6.88696940 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 6.49037835 |
| 9 | negative regulation of fibrinolysis (GO:0051918) | 6.30553626 |
| 10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.27403794 |
| 11 | heme transport (GO:0015886) | 6.16027171 |
| 12 | tryptophan catabolic process (GO:0006569) | 6.03756080 |
| 13 | indole-containing compound catabolic process (GO:0042436) | 6.03756080 |
| 14 | indolalkylamine catabolic process (GO:0046218) | 6.03756080 |
| 15 | high-density lipoprotein particle remodeling (GO:0034375) | 5.99996890 |
| 16 | regulation of cholesterol esterification (GO:0010872) | 5.98166974 |
| 17 | regulation of protein activation cascade (GO:2000257) | 5.90889572 |
| 18 | complement activation, alternative pathway (GO:0006957) | 5.89045499 |
| 19 | ethanol oxidation (GO:0006069) | 5.88500257 |
| 20 | urea cycle (GO:0000050) | 5.87615163 |
| 21 | urea metabolic process (GO:0019627) | 5.87615163 |
| 22 | regulation of fibrinolysis (GO:0051917) | 5.85265124 |
| 23 | * acute-phase response (GO:0006953) | 5.73101444 |
| 24 | kynurenine metabolic process (GO:0070189) | 5.70776004 |
| 25 | tryptophan metabolic process (GO:0006568) | 5.58717570 |
| 26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.56682137 |
| 27 | protein carboxylation (GO:0018214) | 5.56682137 |
| 28 | uronic acid metabolic process (GO:0006063) | 5.53389538 |
| 29 | glucuronate metabolic process (GO:0019585) | 5.53389538 |
| 30 | drug metabolic process (GO:0017144) | 5.46400543 |
| 31 | regulation of complement activation (GO:0030449) | 5.40004023 |
| 32 | nitrogen cycle metabolic process (GO:0071941) | 5.36710050 |
| 33 | phospholipid efflux (GO:0033700) | 5.28651432 |
| 34 | glyoxylate metabolic process (GO:0046487) | 5.25741652 |
| 35 | oxidative demethylation (GO:0070989) | 5.24002834 |
| 36 | bile acid biosynthetic process (GO:0006699) | 5.17292238 |
| 37 | regulation of triglyceride catabolic process (GO:0010896) | 5.16448977 |
| 38 | plasma lipoprotein particle remodeling (GO:0034369) | 5.13881597 |
| 39 | protein-lipid complex remodeling (GO:0034368) | 5.13881597 |
| 40 | macromolecular complex remodeling (GO:0034367) | 5.13881597 |
| 41 | reverse cholesterol transport (GO:0043691) | 5.01383615 |
| 42 | negative regulation of hemostasis (GO:1900047) | 5.01195555 |
| 43 | negative regulation of blood coagulation (GO:0030195) | 5.01195555 |
| 44 | phenylpropanoid metabolic process (GO:0009698) | 4.96657507 |
| 45 | negative regulation of sterol transport (GO:0032372) | 4.84385387 |
| 46 | negative regulation of cholesterol transport (GO:0032375) | 4.84385387 |
| 47 | ethanol metabolic process (GO:0006067) | 4.78088341 |
| 48 | cysteine metabolic process (GO:0006534) | 4.72648365 |
| 49 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.71773417 |
| 50 | sulfur amino acid catabolic process (GO:0000098) | 4.71086406 |
| 51 | aromatic amino acid family metabolic process (GO:0009072) | 4.68587831 |
| 52 | plasma lipoprotein particle clearance (GO:0034381) | 4.67228566 |
| 53 | serine family amino acid catabolic process (GO:0009071) | 4.65787482 |
| 54 | opsonization (GO:0008228) | 4.61569364 |
| 55 | alpha-linolenic acid metabolic process (GO:0036109) | 4.61175105 |
| 56 | negative regulation of coagulation (GO:0050819) | 4.56217708 |
| 57 | negative regulation of wound healing (GO:0061045) | 4.55343472 |
| 58 | tyrosine metabolic process (GO:0006570) | 4.53009987 |
| 59 | cholesterol efflux (GO:0033344) | 4.50404164 |
| 60 | fibrinolysis (GO:0042730) | 4.50287784 |
| 61 | plasma lipoprotein particle assembly (GO:0034377) | 4.44382167 |
| 62 | positive regulation of hemostasis (GO:1900048) | 4.41244659 |
| 63 | positive regulation of blood coagulation (GO:0030194) | 4.41244659 |
| 64 | bile acid metabolic process (GO:0008206) | 4.39529275 |
| 65 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.38086042 |
| 66 | iron coordination entity transport (GO:1901678) | 4.37209199 |
| 67 | acylglycerol homeostasis (GO:0055090) | 4.35783588 |
| 68 | triglyceride homeostasis (GO:0070328) | 4.35783588 |
| 69 | negative regulation of lipase activity (GO:0060192) | 4.32778743 |
| 70 | benzene-containing compound metabolic process (GO:0042537) | 4.27721813 |
| 71 | homocysteine metabolic process (GO:0050667) | 4.23277384 |
| 72 | negative regulation of protein activation cascade (GO:2000258) | 4.23165599 |
| 73 | alpha-amino acid catabolic process (GO:1901606) | 4.23159791 |
| 74 | indolalkylamine metabolic process (GO:0006586) | 4.16736529 |
| 75 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.16676942 |
| 76 | negative regulation of complement activation (GO:0045916) | 4.15008650 |
| 77 | arginine metabolic process (GO:0006525) | 4.12841184 |
| 78 | amine catabolic process (GO:0009310) | 4.12432137 |
| 79 | cellular biogenic amine catabolic process (GO:0042402) | 4.12432137 |
| 80 | intestinal cholesterol absorption (GO:0030299) | 4.12344229 |
| 81 | complement activation, classical pathway (GO:0006958) | 4.10709507 |
| 82 | positive regulation of coagulation (GO:0050820) | 4.05726966 |
| 83 | protein activation cascade (GO:0072376) | 4.05061038 |
| 84 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.04509663 |
| 85 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.04509663 |
| 86 | lysine metabolic process (GO:0006553) | 4.03444757 |
| 87 | lysine catabolic process (GO:0006554) | 4.03444757 |
| 88 | complement activation (GO:0006956) | 4.01692405 |
| 89 | blood coagulation, intrinsic pathway (GO:0007597) | 4.01573256 |
| 90 | S-adenosylmethionine metabolic process (GO:0046500) | 4.01348009 |
| 91 | regulation of apoptotic cell clearance (GO:2000425) | 4.00100331 |
| 92 | protein-lipid complex assembly (GO:0065005) | 3.97537454 |
| 93 | hormone catabolic process (GO:0042447) | 3.96470389 |
| 94 | alkaloid metabolic process (GO:0009820) | 3.96225919 |
| 95 | coenzyme catabolic process (GO:0009109) | 3.95143756 |
| 96 | * acute inflammatory response (GO:0002526) | 3.89197204 |
| 97 | amino-acid betaine metabolic process (GO:0006577) | 3.87496817 |
| 98 | plasma lipoprotein particle organization (GO:0071827) | 3.86034122 |
| 99 | positive regulation of lipid catabolic process (GO:0050996) | 3.85446681 |
| 100 | glutamate metabolic process (GO:0006536) | 3.83319266 |
| 101 | cellular amino acid catabolic process (GO:0009063) | 3.82751390 |
| 102 | regulation of humoral immune response (GO:0002920) | 3.81284904 |
| 103 | regulation of plasminogen activation (GO:0010755) | 3.80582776 |
| 104 | cofactor catabolic process (GO:0051187) | 3.79018245 |
| 105 | drug catabolic process (GO:0042737) | 3.77622609 |
| 106 | low-density lipoprotein particle remodeling (GO:0034374) | 3.77150888 |
| 107 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.76943860 |
| 108 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.76652928 |
| 109 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.76652928 |
| 110 | cellular modified amino acid catabolic process (GO:0042219) | 3.73271159 |
| 111 | bile acid and bile salt transport (GO:0015721) | 3.72787584 |
| 112 | glycine metabolic process (GO:0006544) | 3.69501909 |
| 113 | response to phenylpropanoid (GO:0080184) | 3.69210683 |
| 114 | imidazole-containing compound metabolic process (GO:0052803) | 3.65751976 |
| 115 | serine family amino acid metabolic process (GO:0009069) | 3.65588127 |
| 116 | regulation of lipoprotein particle clearance (GO:0010984) | 3.65507434 |
| 117 | protein-lipid complex subunit organization (GO:0071825) | 3.62598356 |
| 118 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.62365560 |
| 119 | flavonoid metabolic process (GO:0009812) | 3.59872976 |
| 120 | aldehyde catabolic process (GO:0046185) | 3.58504931 |
| 121 | response to nitrosative stress (GO:0051409) | 3.57436772 |
| 122 | lipoprotein metabolic process (GO:0042157) | 3.56095743 |
| 123 | serine family amino acid biosynthetic process (GO:0009070) | 3.55327948 |
| 124 | cholesterol homeostasis (GO:0042632) | 3.54995240 |
| 125 | cellular glucuronidation (GO:0052695) | 3.54275712 |
| 126 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.53937303 |
| 127 | positive regulation of humoral immune response (GO:0002922) | 3.52996097 |
| 128 | regulation of acute inflammatory response (GO:0002673) | 3.51049069 |
| 129 | sterol homeostasis (GO:0055092) | 3.50118538 |
| 130 | cytolysis (GO:0019835) | 3.49594474 |
| 131 | regulation of bile acid biosynthetic process (GO:0070857) | 3.44549827 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.89344628 |
| 2 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.82032508 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.73658052 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.09572000 |
| 5 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.64319401 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.27620361 |
| 7 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.05028036 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.51141006 |
| 9 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.10989632 |
| 10 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 12.0057431 |
| 11 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.97360553 |
| 12 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.96830420 |
| 13 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.88161533 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.77882767 |
| 15 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.74651965 |
| 16 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.58471336 |
| 17 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.57038883 |
| 18 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.56986092 |
| 19 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.51349658 |
| 20 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.50589510 |
| 21 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.30555720 |
| 22 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.26956312 |
| 23 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.22089059 |
| 24 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.20878509 |
| 25 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.20562528 |
| 26 | GATA1_22025678_ChIP-Seq_K562_Human | 1.14978651 |
| 27 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.13964889 |
| 28 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.07274230 |
| 29 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03755803 |
| 30 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.02093238 |
| 31 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.00551457 |
| 32 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.94461822 |
| 33 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.93875013 |
| 34 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.87906156 |
| 35 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.86392602 |
| 36 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.83556129 |
| 37 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.81539293 |
| 38 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.81494592 |
| 39 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.81174253 |
| 40 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.80259998 |
| 41 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.79133329 |
| 42 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.77915857 |
| 43 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.77757036 |
| 44 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.77003512 |
| 45 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.76315071 |
| 46 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.73171873 |
| 47 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.71870289 |
| 48 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.71764661 |
| 49 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.70677152 |
| 50 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.67810553 |
| 51 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.67743703 |
| 52 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.67437897 |
| 53 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.66402459 |
| 54 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.65735517 |
| 55 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.65735517 |
| 56 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.64986068 |
| 57 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.64813456 |
| 58 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.63842652 |
| 59 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.63046473 |
| 60 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.62432303 |
| 61 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.62088990 |
| 62 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.60848207 |
| 63 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.60558172 |
| 64 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.59731212 |
| 65 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.58571162 |
| 66 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.58377957 |
| 67 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.58228303 |
| 68 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.57975141 |
| 69 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.57893446 |
| 70 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.57589300 |
| 71 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.55792913 |
| 72 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.55790490 |
| 73 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.55785317 |
| 74 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.55657456 |
| 75 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.55641553 |
| 76 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.55166843 |
| 77 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.55130763 |
| 78 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.55011291 |
| 79 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.54672110 |
| 80 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.54239748 |
| 81 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.53108947 |
| 82 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.52779066 |
| 83 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.52752341 |
| 84 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.52509188 |
| 85 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.52468979 |
| 86 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.52396201 |
| 87 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.52272723 |
| 88 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.52116669 |
| 89 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.51940910 |
| 90 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.50849221 |
| 91 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.50796298 |
| 92 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.50507387 |
| 93 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.50286742 |
| 94 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.49858214 |
| 95 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.49811676 |
| 96 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.49474785 |
| 97 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.49346400 |
| 98 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.49269357 |
| 99 | AR_20517297_ChIP-Seq_VCAP_Human | 0.49256944 |
| 100 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.49194321 |
| 101 | * KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.48967849 |
| 102 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.48681887 |
| 103 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.47990170 |
| 104 | CBP_21632823_ChIP-Seq_H3396_Human | 0.45480607 |
| 105 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.45362144 |
| 106 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.44800052 |
| 107 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.44298858 |
| 108 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.43098540 |
| 109 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.42935236 |
| 110 | GATA2_19941826_ChIP-Seq_K562_Human | 0.42685267 |
| 111 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.42596942 |
| 112 | * TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.42008008 |
| 113 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.41881747 |
| 114 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.41546841 |
| 115 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.41479546 |
| 116 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.40941464 |
| 117 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.40349061 |
| 118 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.40224778 |
| 119 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.39828886 |
| 120 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.39687497 |
| 121 | GATA1_19941826_ChIP-Seq_K562_Human | 0.39175179 |
| 122 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.38851897 |
| 123 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.38455492 |
| 124 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.37466653 |
| 125 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.37463816 |
| 126 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.37135456 |
| 127 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.37084674 |
| 128 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.36855118 |
| 129 | NCOR_22424771_ChIP-Seq_293T_Human | 0.36705943 |
| 130 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.36497032 |
| 131 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.36283181 |
| 132 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.36140357 |
| 133 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.36082739 |
| 134 | * P53_21459846_ChIP-Seq_SAOS-2_Human | 0.36044518 |
| 135 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.35646074 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.18544255 |
| 2 | MP0005360_urolithiasis | 7.35032263 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.15023547 |
| 4 | MP0005365_abnormal_bile_salt | 6.09560059 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.70283255 |
| 6 | MP0009840_abnormal_foam_cell | 3.72903859 |
| 7 | MP0003191_abnormal_cellular_cholesterol | 3.66122890 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.65792908 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.50992866 |
| 10 | MP0003252_abnormal_bile_duct | 3.38421129 |
| 11 | MP0005083_abnormal_biliary_tract | 2.96634801 |
| 12 | MP0005332_abnormal_amino_acid | 2.78495117 |
| 13 | MP0003195_calcinosis | 2.70238648 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.46706015 |
| 15 | MP0000609_abnormal_liver_physiology | 2.16907519 |
| 16 | MP0002138_abnormal_hepatobiliary_system | 2.14694348 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.09973895 |
| 18 | MP0004019_abnormal_vitamin_homeostasis | 2.08508135 |
| 19 | MP0005319_abnormal_enzyme/_coenzyme | 1.76911090 |
| 20 | MP0003011_delayed_dark_adaptation | 1.60816689 |
| 21 | MP0001764_abnormal_homeostasis | 1.59475099 |
| 22 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.52156319 |
| 23 | MP0003868_abnormal_feces_composition | 1.45068195 |
| 24 | MP0000604_amyloidosis | 1.44515275 |
| 25 | MP0009697_abnormal_copulation | 1.40387402 |
| 26 | MP0009643_abnormal_urine_homeostasis | 1.35722613 |
| 27 | MP0009764_decreased_sensitivity_to | 1.32630471 |
| 28 | MP0009763_increased_sensitivity_to | 1.23587841 |
| 29 | MP0003705_abnormal_hypodermis_morpholog | 1.23012870 |
| 30 | MP0005636_abnormal_mineral_homeostasis | 1.18066004 |
| 31 | MP0002132_abnormal_respiratory_system | 1.16311908 |
| 32 | MP0000598_abnormal_liver_morphology | 1.15852407 |
| 33 | MP0003656_abnormal_erythrocyte_physiolo | 1.14080050 |
| 34 | MP0002254_reproductive_system_inflammat | 1.13029134 |
| 35 | MP0008469_abnormal_protein_level | 1.11686484 |
| 36 | MP0003186_abnormal_redox_activity | 1.11049770 |
| 37 | MP0005670_abnormal_white_adipose | 1.07300597 |
| 38 | MP0001915_intracranial_hemorrhage | 1.06441324 |
| 39 | MP0001881_abnormal_mammary_gland | 1.03328986 |
| 40 | MP0005647_abnormal_sex_gland | 0.98616981 |
| 41 | MP0003690_abnormal_glial_cell | 0.97470673 |
| 42 | MP0009642_abnormal_blood_homeostasis | 0.96106733 |
| 43 | MP0005464_abnormal_platelet_physiology | 0.88266935 |
| 44 | MP0009765_abnormal_xenobiotic_induced | 0.87512777 |
| 45 | MP0002971_abnormal_brown_adipose | 0.84212448 |
| 46 | MP0005451_abnormal_body_composition | 0.83321376 |
| 47 | MP0010368_abnormal_lymphatic_system | 0.82394992 |
| 48 | MP0005376_homeostasis/metabolism_phenot | 0.77966799 |
| 49 | MP0003329_amyloid_beta_deposits | 0.77599101 |
| 50 | MP0009053_abnormal_anal_canal | 0.76952932 |
| 51 | MP0003436_decreased_susceptibility_to | 0.75701083 |
| 52 | MP0005408_hypopigmentation | 0.74314467 |
| 53 | MP0005084_abnormal_gallbladder_morpholo | 0.71752124 |
| 54 | MP0005187_abnormal_penis_morphology | 0.71467345 |
| 55 | MP0002078_abnormal_glucose_homeostasis | 0.71087263 |
| 56 | MP0003879_abnormal_hair_cell | 0.70332788 |
| 57 | MP0005220_abnormal_exocrine_pancreas | 0.69642311 |
| 58 | MP0005334_abnormal_fat_pad | 0.69187296 |
| 59 | MP0001661_extended_life_span | 0.68081953 |
| 60 | MP0006036_abnormal_mitochondrial_physio | 0.68035796 |
| 61 | MP0003724_increased_susceptibility_to | 0.66126908 |
| 62 | MP0000639_abnormal_adrenal_gland | 0.65053202 |
| 63 | MP0004130_abnormal_muscle_cell | 0.64416148 |
| 64 | MP0002282_abnormal_trachea_morphology | 0.62333447 |
| 65 | MP0001756_abnormal_urination | 0.59895657 |
| 66 | MP0005535_abnormal_body_temperature | 0.58129159 |
| 67 | MP0002136_abnormal_kidney_physiology | 0.57267847 |
| 68 | MP0005395_other_phenotype | 0.56775628 |
| 69 | MP0003075_altered_response_to | 0.56516029 |
| 70 | MP0008873_increased_physiological_sensi | 0.55574655 |
| 71 | MP0005166_decreased_susceptibility_to | 0.54279354 |
| 72 | MP0000566_synostosis | 0.54014511 |
| 73 | MP0002089_abnormal_postnatal_growth/wei | 0.53720703 |
| 74 | MP0002876_abnormal_thyroid_physiology | 0.53465513 |
| 75 | MP0005023_abnormal_wound_healing | 0.52523907 |
| 76 | MP0005448_abnormal_energy_balance | 0.50445898 |
| 77 | MP0003638_abnormal_response/metabolism_ | 0.49811404 |
| 78 | MP0008874_decreased_physiological_sensi | 0.48874422 |
| 79 | MP0002249_abnormal_larynx_morphology | 0.48500434 |
| 80 | MP0005666_abnormal_adipose_tissue | 0.47580329 |
| 81 | MP0005164_abnormal_response_to | 0.46601442 |
| 82 | MP0005266_abnormal_metabolism | 0.45795473 |
| 83 | MP0000579_abnormal_nail_morphology | 0.45246745 |
| 84 | MP0001845_abnormal_inflammatory_respons | 0.45087130 |
| 85 | MP0004883_abnormal_blood_vessel | 0.44831342 |
| 86 | MP0000249_abnormal_blood_vessel | 0.43031720 |
| 87 | MP0009384_cardiac_valve_regurgitation | 0.42278202 |
| 88 | MP0009785_altered_susceptibility_to | 0.42191675 |
| 89 | MP0008872_abnormal_physiological_respon | 0.41353917 |
| 90 | MP0003122_maternal_imprinting | 0.40267571 |
| 91 | MP0002796_impaired_skin_barrier | 0.38830833 |
| 92 | MP0002168_other_aberrant_phenotype | 0.38309197 |
| 93 | MP0009115_abnormal_fat_cell | 0.37351041 |
| 94 | MP0004264_abnormal_extraembryonic_tissu | 0.37104968 |
| 95 | MP0002135_abnormal_kidney_morphology | 0.35774817 |
| 96 | MP0003453_abnormal_keratinocyte_physiol | 0.35004532 |
| 97 | MP0003718_maternal_effect | 0.34323445 |
| 98 | MP0003953_abnormal_hormone_level | 0.33983834 |
| 99 | MP0005025_abnormal_response_to | 0.33831435 |
| 100 | MP0005167_abnormal_blood-brain_barrier | 0.33536794 |
| 101 | MP0003172_abnormal_lysosome_physiology | 0.33481274 |
| 102 | MP0003300_gastrointestinal_ulcer | 0.33210544 |
| 103 | MP0001243_abnormal_dermal_layer | 0.32331730 |
| 104 | MP0006035_abnormal_mitochondrial_morpho | 0.32242886 |
| 105 | MP0006082_CNS_inflammation | 0.32070896 |
| 106 | MP0005058_abnormal_lysosome_morphology | 0.31850485 |
| 107 | MP0003303_peritoneal_inflammation | 0.31664802 |
| 108 | MP0002419_abnormal_innate_immunity | 0.31406297 |
| 109 | MP0002970_abnormal_white_adipose | 0.31385802 |
| 110 | MP0002928_abnormal_bile_duct | 0.30334820 |
| 111 | MP0005248_abnormal_Harderian_gland | 0.28897294 |
| 112 | MP0004272_abnormal_basement_membrane | 0.27028440 |
| 113 | MP0000920_abnormal_myelination | 0.25382828 |
| 114 | MP0002090_abnormal_vision | 0.25342854 |
| 115 | MP0003959_abnormal_lean_body | 0.23390517 |
| 116 | MP0001851_eye_inflammation | 0.20778480 |
| 117 | MP0003632_abnormal_nervous_system | 0.20773518 |
| 118 | MP0005197_abnormal_uvea_morphology | 0.19777515 |
| 119 | MP0002128_abnormal_blood_circulation | 0.19617342 |
| 120 | MP0000467_abnormal_esophagus_morphology | 0.18833507 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.43046313 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.15179686 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 7.06148793 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.78732659 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 6.51959955 |
| 6 | Complement deficiency (HP:0004431) | 6.39642166 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.98611070 |
| 8 | Xanthomatosis (HP:0000991) | 5.98309580 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.65239786 |
| 10 | Abnormality of the common coagulation pathway (HP:0010990) | 5.48355467 |
| 11 | Joint hemorrhage (HP:0005261) | 5.16607343 |
| 12 | Spontaneous abortion (HP:0005268) | 4.93809287 |
| 13 | Abnormality of complement system (HP:0005339) | 4.69112354 |
| 14 | Hypolipoproteinemia (HP:0010981) | 4.66960334 |
| 15 | Hyperammonemia (HP:0001987) | 4.34464974 |
| 16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.32113956 |
| 17 | Abnormality of methionine metabolism (HP:0010901) | 4.27715853 |
| 18 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.26394703 |
| 19 | Hypoalphalipoproteinemia (HP:0003233) | 4.25661273 |
| 20 | Epidermoid cyst (HP:0200040) | 4.20627994 |
| 21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.14580504 |
| 22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.08435099 |
| 23 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.03392461 |
| 24 | Ketosis (HP:0001946) | 3.94486614 |
| 25 | Abnormality of the intrinsic pathway (HP:0010989) | 3.85588611 |
| 26 | Fat malabsorption (HP:0002630) | 3.83544957 |
| 27 | Hypoglycemic coma (HP:0001325) | 3.72409362 |
| 28 | Hyperglycinemia (HP:0002154) | 3.68016316 |
| 29 | Hypercholesterolemia (HP:0003124) | 3.52841796 |
| 30 | Amyloidosis (HP:0011034) | 3.51397676 |
| 31 | Gingival bleeding (HP:0000225) | 3.48287648 |
| 32 | Glomerulonephritis (HP:0000099) | 3.32503174 |
| 33 | Systemic lupus erythematosus (HP:0002725) | 3.28913848 |
| 34 | Conjugated hyperbilirubinemia (HP:0002908) | 3.25014004 |
| 35 | Hyperglycinuria (HP:0003108) | 3.23313523 |
| 36 | Abnormality of glycine metabolism (HP:0010895) | 3.20073473 |
| 37 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.20073473 |
| 38 | Abnormality of nucleobase metabolism (HP:0010932) | 3.19029597 |
| 39 | Hyperbilirubinemia (HP:0002904) | 2.98650711 |
| 40 | Steatorrhea (HP:0002570) | 2.97457158 |
| 41 | Myocardial infarction (HP:0001658) | 2.97040030 |
| 42 | Generalized aminoaciduria (HP:0002909) | 2.94985087 |
| 43 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.91286851 |
| 44 | Purpura (HP:0000979) | 2.90556983 |
| 45 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.86831365 |
| 46 | Abnormality of iron homeostasis (HP:0011031) | 2.85728335 |
| 47 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.83084769 |
| 48 | Ketoacidosis (HP:0001993) | 2.80669382 |
| 49 | Abnormality of purine metabolism (HP:0004352) | 2.76848165 |
| 50 | Osteomalacia (HP:0002749) | 2.76712390 |
| 51 | Thrombophlebitis (HP:0004418) | 2.72536644 |
| 52 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.68807107 |
| 53 | Hepatocellular carcinoma (HP:0001402) | 2.68122502 |
| 54 | Abnormality of serum amino acid levels (HP:0003112) | 2.67044050 |
| 55 | Skin nodule (HP:0200036) | 2.64096533 |
| 56 | Hypochromic microcytic anemia (HP:0004840) | 2.61228777 |
| 57 | Mitral stenosis (HP:0001718) | 2.61223366 |
| 58 | Reduced antithrombin III activity (HP:0001976) | 2.57947537 |
| 59 | Vascular calcification (HP:0004934) | 2.56124104 |
| 60 | Hypoglycemic seizures (HP:0002173) | 2.55842411 |
| 61 | Nephritis (HP:0000123) | 2.52683031 |
| 62 | Lethargy (HP:0001254) | 2.49264958 |
| 63 | Spastic diplegia (HP:0001264) | 2.42958723 |
| 64 | Late onset (HP:0003584) | 2.40544571 |
| 65 | Cerebral edema (HP:0002181) | 2.40500399 |
| 66 | Delayed CNS myelination (HP:0002188) | 2.38847940 |
| 67 | Gout (HP:0001997) | 2.38837944 |
| 68 | Metabolic acidosis (HP:0001942) | 2.37827392 |
| 69 | Irritability (HP:0000737) | 2.36804548 |
| 70 | Menorrhagia (HP:0000132) | 2.36211865 |
| 71 | Neonatal onset (HP:0003623) | 2.35894385 |
| 72 | Cardiovascular calcification (HP:0011915) | 2.28143761 |
| 73 | Esophageal varix (HP:0002040) | 2.23906349 |
| 74 | Arthropathy (HP:0003040) | 2.19788889 |
| 75 | Abnormal gallbladder morphology (HP:0012437) | 2.19582943 |
| 76 | Joint swelling (HP:0001386) | 2.19524992 |
| 77 | Cholecystitis (HP:0001082) | 2.18095075 |
| 78 | Abnormal gallbladder physiology (HP:0012438) | 2.18095075 |
| 79 | Cholelithiasis (HP:0001081) | 2.15961687 |
| 80 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.11691179 |
| 81 | Acanthocytosis (HP:0001927) | 2.04902361 |
| 82 | Abnormality of the Achilles tendon (HP:0005109) | 2.04692954 |
| 83 | Hyperphosphaturia (HP:0003109) | 2.04046904 |
| 84 | Dicarboxylic aciduria (HP:0003215) | 2.03766762 |
| 85 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.03766762 |
| 86 | Fair hair (HP:0002286) | 2.03314328 |
| 87 | Pancreatitis (HP:0001733) | 2.00266676 |
| 88 | Vomiting (HP:0002013) | 1.98116709 |
| 89 | Gangrene (HP:0100758) | 1.96668351 |
| 90 | Sensorimotor neuropathy (HP:0007141) | 1.95211036 |
| 91 | Opisthotonus (HP:0002179) | 1.95168524 |
| 92 | Enlarged kidneys (HP:0000105) | 1.90448277 |
| 93 | Hyperglycemia (HP:0003074) | 1.88552944 |
| 94 | Epistaxis (HP:0000421) | 1.88193737 |
| 95 | Brushfield spots (HP:0001088) | 1.88111399 |
| 96 | Abnormality of urine glucose concentration (HP:0011016) | 1.85064612 |
| 97 | Glycosuria (HP:0003076) | 1.85064612 |
| 98 | Hemorrhage of the eye (HP:0011885) | 1.83543597 |
| 99 | Elevated alkaline phosphatase (HP:0003155) | 1.83408295 |
| 100 | Rickets (HP:0002748) | 1.81506961 |
| 101 | Alkalosis (HP:0001948) | 1.81432828 |
| 102 | Bifid scrotum (HP:0000048) | 1.80852686 |
| 103 | Increased serum ferritin (HP:0003281) | 1.80691982 |
| 104 | Malnutrition (HP:0004395) | 1.79086975 |
| 105 | Hypophosphatemic rickets (HP:0004912) | 1.78006719 |
| 106 | Abnormality of the gallbladder (HP:0005264) | 1.77752734 |
| 107 | Abnormal cartilage morphology (HP:0002763) | 1.76123878 |
| 108 | Symptomatic seizures (HP:0011145) | 1.74820150 |
| 109 | Pulmonary embolism (HP:0002204) | 1.74113631 |
| 110 | Abnormality of vitamin metabolism (HP:0100508) | 1.72887613 |
| 111 | Back pain (HP:0003418) | 1.70341471 |
| 112 | Hypertriglyceridemia (HP:0002155) | 1.70104476 |
| 113 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.69520143 |
| 114 | Hydroxyprolinuria (HP:0003080) | 1.68721852 |
| 115 | Abnormality of proline metabolism (HP:0010907) | 1.68721852 |
| 116 | Neonatal hypoglycemia (HP:0001998) | 1.67555431 |
| 117 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.67490480 |
| 118 | Abnormal urine phosphate concentration (HP:0012599) | 1.66519542 |
| 119 | Increased serum pyruvate (HP:0003542) | 1.66490659 |
| 120 | Poikilocytosis (HP:0004447) | 1.65723713 |
| 121 | Abnormal tarsal ossification (HP:0008369) | 1.65507129 |
| 122 | Abnormal delivery (HP:0001787) | 1.64467141 |
| 123 | Increased mean platelet volume (HP:0011877) | 1.59670159 |
| 124 | Abnormal platelet function (HP:0011869) | 1.52976730 |
| 125 | Impaired platelet aggregation (HP:0003540) | 1.52976730 |
| 126 | Potter facies (HP:0002009) | 1.52862374 |
| 127 | Facial shape deformation (HP:0011334) | 1.52862374 |
| 128 | Abnormal biliary tract physiology (HP:0012439) | 1.52602745 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.29396211 |
| 2 | ERN1 | 5.99437525 |
| 3 | FGFR4 | 4.94681933 |
| 4 | SIK1 | 3.32783284 |
| 5 | ERBB4 | 3.10506540 |
| 6 | TAOK3 | 3.03008049 |
| 7 | DAPK2 | 2.60913592 |
| 8 | INSRR | 2.35959693 |
| 9 | EPHB1 | 2.10224136 |
| 10 | EPHA3 | 2.06181680 |
| 11 | MAP2K4 | 2.04948267 |
| 12 | TRIB3 | 2.03524684 |
| 13 | MST1R | 1.86265699 |
| 14 | PTK6 | 1.82286019 |
| 15 | TYK2 | 1.81977557 |
| 16 | PIK3CG | 1.78342772 |
| 17 | MAPK11 | 1.77806716 |
| 18 | PRPF4B | 1.57231980 |
| 19 | NTRK3 | 1.49815081 |
| 20 | NEK9 | 1.42469848 |
| 21 | PKN2 | 1.39572738 |
| 22 | JAK2 | 1.39296693 |
| 23 | TBK1 | 1.38054947 |
| 24 | GRK6 | 1.33976328 |
| 25 | CDK12 | 1.32903337 |
| 26 | JAK1 | 1.24644542 |
| 27 | ABL2 | 1.20643535 |
| 28 | ERBB2 | 1.18802817 |
| 29 | EIF2AK1 | 1.14382597 |
| 30 | MAP3K14 | 1.14006083 |
| 31 | LATS1 | 1.12423987 |
| 32 | RIPK1 | 1.11045603 |
| 33 | PIK3CA | 1.09817839 |
| 34 | FLT3 | 1.09737785 |
| 35 | MAP3K2 | 1.08955103 |
| 36 | PDGFRA | 1.08471258 |
| 37 | MAP3K7 | 1.06913395 |
| 38 | FRK | 1.06544013 |
| 39 | CAMK1D | 1.04216318 |
| 40 | IRAK3 | 1.02369458 |
| 41 | MAPK12 | 0.94886620 |
| 42 | PRKAA2 | 0.94386543 |
| 43 | WNK4 | 0.94318928 |
| 44 | MAP3K11 | 0.92225480 |
| 45 | CAMK2G | 0.91675638 |
| 46 | FGFR1 | 0.88191546 |
| 47 | FGFR2 | 0.84179774 |
| 48 | MAPK4 | 0.82313851 |
| 49 | AKT3 | 0.81714757 |
| 50 | PRKG1 | 0.81109647 |
| 51 | TNK2 | 0.80723109 |
| 52 | TGFBR2 | 0.80463884 |
| 53 | KDR | 0.80168961 |
| 54 | PRKCZ | 0.79245641 |
| 55 | MAP2K3 | 0.78556497 |
| 56 | MET | 0.77555065 |
| 57 | IKBKE | 0.77403130 |
| 58 | PRKACG | 0.77055189 |
| 59 | FGFR3 | 0.75162357 |
| 60 | MAP2K1 | 0.71554874 |
| 61 | SGK1 | 0.70263848 |
| 62 | MAPKAPK3 | 0.69862799 |
| 63 | MAP3K3 | 0.68847515 |
| 64 | CAMKK2 | 0.68458114 |
| 65 | CSNK1D | 0.66704646 |
| 66 | CSK | 0.64964315 |
| 67 | MAP2K6 | 0.64865132 |
| 68 | DYRK1B | 0.63417970 |
| 69 | PRKACA | 0.63217902 |
| 70 | TAOK2 | 0.62902253 |
| 71 | PKN1 | 0.62373510 |
| 72 | GSK3A | 0.62049340 |
| 73 | SCYL2 | 0.60941456 |
| 74 | PDK2 | 0.60889072 |
| 75 | MAP3K13 | 0.59173725 |
| 76 | CSF1R | 0.58974116 |
| 77 | PTK2 | 0.58364194 |
| 78 | CDK4 | 0.57716313 |
| 79 | MAP3K12 | 0.55792812 |
| 80 | CDK6 | 0.53849711 |
| 81 | CAMKK1 | 0.53616029 |
| 82 | PDPK1 | 0.53558782 |
| 83 | RPS6KA3 | 0.53427182 |
| 84 | KSR2 | 0.53373696 |
| 85 | MAP3K5 | 0.52818841 |
| 86 | SGK2 | 0.52177674 |
| 87 | PRKCB | 0.52170567 |
| 88 | PINK1 | 0.51298573 |
| 89 | SRC | 0.48837508 |
| 90 | CAMK1G | 0.48756626 |
| 91 | MAP3K10 | 0.48541903 |
| 92 | RET | 0.48412362 |
| 93 | EGFR | 0.47461614 |
| 94 | IGF1R | 0.46316553 |
| 95 | CSNK2A2 | 0.46196394 |
| 96 | EPHA4 | 0.45121679 |
| 97 | MAPK15 | 0.44048508 |
| 98 | MAPK7 | 0.43643286 |
| 99 | MAP3K6 | 0.42802374 |
| 100 | MAP3K1 | 0.42626891 |
| 101 | PRKCQ | 0.42436983 |
| 102 | CSNK2A1 | 0.42011344 |
| 103 | BMX | 0.41896760 |
| 104 | MAP4K1 | 0.41062908 |
| 105 | PRKCG | 0.40868739 |
| 106 | CAMK4 | 0.39900291 |
| 107 | MTOR | 0.39138480 |
| 108 | EPHA2 | 0.38960335 |
| 109 | IRAK1 | 0.38273078 |
| 110 | SGK3 | 0.37811063 |
| 111 | RPS6KB1 | 0.37475231 |
| 112 | KIT | 0.36995172 |
| 113 | PRKAA1 | 0.36697715 |
| 114 | BLK | 0.36112853 |
| 115 | CDK7 | 0.34781860 |
| 116 | MYLK | 0.34198777 |
| 117 | ZAP70 | 0.33947922 |
| 118 | STK38L | 0.33641187 |
| 119 | ICK | 0.33513666 |
| 120 | DAPK3 | 0.33442765 |
| 121 | TIE1 | 0.32545058 |
| 122 | PAK3 | 0.32496523 |
| 123 | PDK1 | 0.32137502 |
| 124 | MAPK3 | 0.31553863 |
| 125 | NLK | 0.29084529 |
| 126 | PRKACB | 0.28452049 |
| 127 | PRKCA | 0.27401476 |
| 128 | FER | 0.26537232 |
| 129 | CSNK1E | 0.26177404 |
| 130 | IKBKB | 0.25715935 |
| 131 | CSNK1G1 | 0.25629810 |
| 132 | SGK494 | 0.25194946 |
| 133 | SGK223 | 0.25194946 |
| 134 | JAK3 | 0.23612993 |
| 135 | EPHB2 | 0.23537100 |
| 136 | PRKCH | 0.22343139 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.44650672 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.89278516 |
| 3 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.47801578 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.45701445 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.31055657 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.02022274 |
| 7 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.60287289 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.57719081 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.39357093 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.32516201 |
| 11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.32497911 |
| 12 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.31578860 |
| 13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.17095239 |
| 14 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.16629256 |
| 15 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.12932903 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.10066735 |
| 17 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.02076402 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.01223341 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 2.00544004 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.86058917 |
| 21 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.80248403 |
| 22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.79885746 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.78941246 |
| 24 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.72734107 |
| 25 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.69810289 |
| 26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.64869261 |
| 27 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.60380956 |
| 28 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.59214777 |
| 29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.55389323 |
| 30 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.55055129 |
| 31 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.50084411 |
| 32 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.49453234 |
| 33 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.49334849 |
| 34 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.47110112 |
| 35 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.44378130 |
| 36 | Retinol metabolism_Homo sapiens_hsa00830 | 1.44111008 |
| 37 | Bile secretion_Homo sapiens_hsa04976 | 1.42234516 |
| 38 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.40708742 |
| 39 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.38361613 |
| 40 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.33293870 |
| 41 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.29034001 |
| 42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.25414336 |
| 43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.22744848 |
| 44 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.18110672 |
| 45 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.14828011 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 1.13867231 |
| 47 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.12075578 |
| 48 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.11087628 |
| 49 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.08798549 |
| 50 | Carbon metabolism_Homo sapiens_hsa01200 | 1.07891927 |
| 51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.07809337 |
| 52 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.98689844 |
| 53 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.95972839 |
| 54 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.95172416 |
| 55 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.94755199 |
| 56 | Sulfur relay system_Homo sapiens_hsa04122 | 0.94376359 |
| 57 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.91323276 |
| 58 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.88730606 |
| 59 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.87468329 |
| 60 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.83581386 |
| 61 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.82293921 |
| 62 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.80143558 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69176908 |
| 64 | Lysine degradation_Homo sapiens_hsa00310 | 0.64167247 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.62599106 |
| 66 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.55841148 |
| 67 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.53805922 |
| 68 | Prion diseases_Homo sapiens_hsa05020 | 0.51207940 |
| 69 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.44812034 |
| 70 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40965100 |
| 71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.38148769 |
| 72 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.32212451 |
| 73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.26733819 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.24778447 |
| 75 | Other glycan degradation_Homo sapiens_hsa00511 | 0.21560501 |
| 76 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.11900464 |
| 77 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.11069098 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.10274917 |
| 79 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.08898722 |
| 80 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.05290135 |
| 81 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.03389851 |
| 82 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2274566 |
| 83 | Prolactin signaling pathway_Homo sapiens_hsa04917 | -0.2253440 |
| 84 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2204712 |
| 85 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.2113419 |
| 86 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.1986999 |
| 87 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.1844379 |
| 88 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1783617 |
| 89 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1758304 |
| 90 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1662359 |
| 91 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1644318 |
| 92 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1593605 |
| 93 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1513230 |
| 94 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1474625 |
| 95 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1447317 |
| 96 | Amoebiasis_Homo sapiens_hsa05146 | -0.1352317 |
| 97 | Bladder cancer_Homo sapiens_hsa05219 | -0.1192990 |
| 98 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1150393 |
| 99 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0995704 |
| 100 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0899094 |
| 101 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.0819779 |
| 102 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0808390 |
| 103 | Pertussis_Homo sapiens_hsa05133 | -0.0786101 |
| 104 | Hepatitis C_Homo sapiens_hsa05160 | -0.0666101 |
| 105 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0600969 |
| 106 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0501215 |
| 107 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0400187 |
| 108 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0307889 |
| 109 | Mineral absorption_Homo sapiens_hsa04978 | -0.0154830 |

